We are live on ! Find out more
INMB icon

INmune Bio
INMB

48 hedge funds and large institutions have $26M invested in INmune Bio in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 3

79% more capital invested

Capital invested by funds: $14.5M → $26M (+$11.5M)

76% more call options, than puts

Call options by funds: $645K | Put options by funds: $367K

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

30% more funds holding

Funds holding: 37 → 48 (+11)

0.95% more ownership

Funds ownership: 11.85% → 12.8% (+0.95%)

Holders
48
Holders Change
+11
Holders Change %
+29.73%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
14
Reduced
9
Closed
3
Calls
$645K
Puts
$367K
Net Calls
+$278K
Net Calls Change
+$436K

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$362K
2
Citigroup
Citigroup
New York
+$301K
3
LNWTC
Laird Norton Wetherby Trust Company
Washington
+$264K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$247K
5
BlackRock
BlackRock
New York
+$210K

Top Sellers

Rank Fund Capital Flow
1
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$782K
2
Group One Trading
Group One Trading
Illinois
-$366K
3
FA
Fermata Advisors
California
-$229K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$125K
5
Simplex Trading
Simplex Trading
Illinois
-$83.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rockefeller Capital Management
26
Rockefeller Capital Management
New York
$205K +$153K +18,220 New
Man Group
27
Man Group
United Kingdom
$176K +$131K +15,654 New
ECM
28
ExodusPoint Capital Management
New York
$168K +$125K +14,948 New
Bank of America
29
Bank of America
North Carolina
$159K +$80.8K +9,640 +216%
FAIM
30
Financial Advocates Investment Management
Washington
$141K +$105K +12,500 New
LCM
31
Laurion Capital Management
New York
$124K +$92.3K +11,011 New
Osaic Holdings
32
Osaic Holdings
Arizona
$120K +$18.4K +2,200 +26%
NA
33
NewEdge Advisors
Louisiana
$117K +$41.9K +5,000 +92%
BPA
34
Beacon Pointe Advisors
California
$117K – – –
LPL Financial
35
LPL Financial
California
$114K – – –
JP Morgan Chase
36
JP Morgan Chase
New York
$39.2K +$29.2K +3,479 New
Group One Trading
37
Group One Trading
Illinois
$26.7K -$366K -43,614 -95%
Simplex Trading
38
Simplex Trading
Illinois
$23K -$83.8K -9,999 -83%
LSA
39
Leonteq Securities AG
Switzerland
$18K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$17.3K -$8.46K -1,009 -40%
VNA
41
Valley National Advisers
Pennsylvania
$11K – – –
CA
42
Clearstead Advisors
Ohio
$4.73K -$3.52K -420 -50%
FDCDDQ
43
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.5K – – –
NS
44
NBC Securities
Alabama
$3K – – –
IA
45
IFP Advisors
Florida
$2.07K – – –
Wells Fargo
46
Wells Fargo
California
$1.63K -$18.6K -2,219 -94%
FIA
47
FNY Investment Advisers
New York
$1K +$838 +100 New
Fidelity Investments
48
Fidelity Investments
Massachusetts
$957 – – –
Squarepoint
49
Squarepoint
New York
– -$70.5K -10,308 Closed
Northwestern Mutual Wealth Management
50
Northwestern Mutual Wealth Management
Wisconsin
– -$29.1K -4,300 Closed
1
2
3

INMB Hedge Fund Activity: Q4 2023 in Review

48 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q4 2023, worth a combined $26M — up 79% from $14.5M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new INMB positions and 3 closed out — a net gain of 11 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $362K. The largest seller was Janney Montgomery Scott, cutting an estimated $782K.

  • 48 institutional investors held INmune Bio (INMB) as of Q4 2023, up from 37 in Q3 2023.
  • Funds reported $26M of INmune Bio stock for Q4 2023, up 79% quarter-over-quarter.
  • 14 funds opened new INmune Bio positions in Q4 2023 and 3 closed out, a net change of +11 holders.
  • The largest INmune Bio buyer in Q4 2023 was Jane Street, an estimated $362K added.
  • The largest INmune Bio seller in Q4 2023 was Janney Montgomery Scott, an estimated $782K sold.

Based on aggregated 13F filings for Q4 2023.